The Intersection of AI Companies and Biopharmacy: The Case of Financière de Tubize S.A.
Artificial Intelligence (AI) has rapidly transformed various industries, including healthcare and finance. In this context, Financière de Tubize S.A. has emerged as a notable player, holding a substantial stake in the biopharmacy group UCB. This article explores the intricate relationship between AI companies and the pharmaceutical sector, focusing on the activities and investments of Financière…